NEW YORK , Sept. 24, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM ) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom investors who were adversely affected by alleged securities fraud between January 8, 2024 and July 25, 2024 . Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form?prid=104488&wire=4 DXCM investors may also contact Joseph E.
Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, on July 25, 2024 , Dexcom announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024.
The Company attributed its results and lowered guidance on their execution of "several key strategic initiatives" which "did not meet [their] high standards." Investors and analysts reacted immediately to DexCom's revelation. The price of DexCom's common stock declined dramatically.
From a closing market price of $107.85 per share on July 25, 2024 , DexCom's stock price fell to $64.00 per share on July 26, 2024 , a decline of about 40.
66% in the span of just a single day. WHAT'S NEXT? If you suffered a loss in DexCom during the relevant time frame, you have until October 21, 2024 to request that the Court appoint you as lead plaintiff. Your.
